Pelosi Peggie has reported significant transactions involving her stock holdings in USANA Health Sciences Inc, a company known for its involvement in the medicinal chemicals and botanical products sector. This filing is notable as it reflects strategic ownership changes that may influence the company's direction and investor sentiment.
Background
Pelosi Peggie is associated with USANA Health Sciences Inc, which is classified under the SIC code for medicinal chemicals and botanical products. The company is based in Salt Lake City, Utah, and has been active in the health and wellness sector. Recent filings indicate ongoing activity regarding stock ownership changes.
What the Filing Says
According to the recent filing dated October 23, 2026, Pelosi Peggie executed two transactions on October 22, 2026. She acquired 1,632 shares of common stock and 935 shares at a price of $14.52 each. Following these transactions, she owns a total of 7,693 shares of common stock.
Impact
This update may affect various stakeholders, including current and potential investors in USANA Health Sciences. The transactions indicate Pelosi's continued investment in the company, which could be interpreted as a positive sign for its future prospects.
What's Next
The filing does not say what happens next.
Additional Transactions
In addition to the acquisition of common stock, the filing also reveals that Pelosi Peggie received 1,632 Restricted Stock Units (RSUs) on October 22, 2026. These RSUs represent a contingent right to receive shares of USANA common stock, with the underlying shares set to vest in four equal installments over the next year, beginning on the date of the transaction.
Ownership Structure
Following these transactions, Pelosi Peggie's total ownership of common stock stands at 7,693 shares, which includes the shares acquired through the RSUs. This reflects her direct ownership status, as indicated in the filing, which confirms that she is not an officer or a ten-percent owner of the company.
Company Information
USANA Health Sciences Inc is incorporated in Utah and operates under the SIC code for medicinal chemicals and botanical products. The company has its business address at 3838 West Parkway Blvd., Salt Lake City, UT, and has a fiscal year end of January 3. The filing does not provide further details on the company's current financial performance or strategic initiatives.
Conclusion
While the filing provides insight into Pelosi Peggie's recent stock transactions, it does not include any information regarding the company's future plans, performance metrics, or broader market conditions that may impact investor sentiment.